Rallybio Historical Balance Sheet

RLYB Stock

USD 0.61 0.06 9.25%

Trend analysis of Rallybio Corp balance sheet accounts such as Other Liabilities of 27.4 K, Net Tangible Assets of 204.5 M, Property Plant And Equipment Net of 506.9 K or Accounts Payable of 264.1 K provides information on Rallybio Corp's total assets, liabilities, and equity, which is the actual value of Rallybio Corp to its prevalent stockholders. By breaking down trends over time using Rallybio Corp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Rallybio Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rallybio Corp is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.

About Rallybio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Rallybio Corp at a specified time, usually calculated after every quarter, six months, or one year. Rallybio Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rallybio Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rallybio currently owns. An asset can also be divided into two categories, current and non-current.

Rallybio Corp Balance Sheet Chart

At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 6.5 M, whereas Other Liabilities is forecasted to decline to about 27.4 K.

Total Assets Other Current Liab Total Current Liabilities Other Liab Property Plant And Equipment Net

Total Assets

Total assets refers to the total amount of Rallybio Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rallybio Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Rallybio Corp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rallybio Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Rallybio Corp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rallybio Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 6.5 M, whereas Other Liabilities is forecasted to decline to about 27.4 K.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	9.3M	8.1M	5.0M	6.5M
Total Assets	180.4M	115.6M	68.1M	130.1M

Other Current Liab Total Assets

Rallybio Corp balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Long Term Investments	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.86	0.86	0.82	-0.92	0.74	0.86	-0.71	-0.59	0.07	0.71	0.33	1.0	0.25	-0.06	0.75	0.85	-0.01	0.82	-0.37	0.78	1.0	1.0	-0.2	0.86	0.65
Other Current Liab	0.86		1.0	0.89	-0.85	0.85	0.97	-0.3	-0.76	-0.04	0.3	0.22	0.85	0.46	-0.38	0.79	0.9	-0.33	0.89	-0.6	0.96	0.86	0.85	-0.5	0.8	0.84
Total Current Liabilities	0.86	1.0		0.85	-0.87	0.83	0.96	-0.29	-0.77	-0.01	0.29	0.15	0.86	0.48	-0.31	0.77	0.91	-0.27	0.85	-0.65	0.96	0.86	0.85	-0.44	0.79	0.85
Total Stockholder Equity	0.82	0.89	0.85		-0.76	0.91	0.89	-0.4	-0.68	-0.3	0.4	0.42	0.81	0.38	-0.6	0.82	0.84	-0.56	1.0	-0.32	0.9	0.82	0.82	-0.71	0.89	0.8
Other Liab	-0.92	-0.85	-0.87	-0.76		-0.83	-0.75	0.54	0.81	0.09	-0.54	-0.03	-0.92	-0.59	0.08	-0.55	-0.96	0.04	-0.76	0.58	-0.85	-0.92	-0.92	0.24	-0.92	-0.82
Net Tangible Assets	0.74	0.85	0.83	0.91	-0.83		0.77	-0.2	-0.92	-0.53	0.2	0.02	0.73	0.71	-0.62	0.57	0.92	-0.59	0.91	-0.57	0.93	0.74	0.73	-0.73	0.92	0.95
Property Plant And Equipment Net	0.86	0.97	0.96	0.89	-0.75	0.77		-0.33	-0.61	0.03	0.33	0.34	0.84	0.25	-0.37	0.89	0.8	-0.33	0.89	-0.5	0.9	0.86	0.85	-0.48	0.72	0.73
Net Debt	-0.71	-0.3	-0.29	-0.4	0.54	-0.2	-0.33		-0.01	-0.33	-1.0	-0.58	-0.72	0.22	-0.36	-0.44	-0.36	-0.38	-0.4	-0.28	-0.19	-0.71	-0.72	-0.27	-0.53	-0.05
Retained Earnings	-0.59	-0.76	-0.77	-0.68	0.81	-0.92	-0.61	-0.01		0.51	0.01	0.34	-0.59	-0.9	0.46	-0.32	-0.9	0.43	-0.68	0.79	-0.87	-0.59	-0.58	0.58	-0.8	-0.96
Accounts Payable	0.07	-0.04	-0.01	-0.3	0.09	-0.53	0.03	-0.33	0.51		0.33	0.34	0.08	-0.56	0.74	0.13	-0.22	0.75	-0.3	0.19	-0.23	0.07	0.08	0.73	-0.35	-0.44
Cash	0.71	0.3	0.29	0.4	-0.54	0.2	0.33	-1.0	0.01	0.33		0.59	0.72	-0.22	0.36	0.44	0.36	0.38	0.4	0.28	0.19	0.71	0.72	0.27	0.53	0.05
Non Current Assets Total	0.33	0.22	0.15	0.42	-0.03	0.02	0.34	-0.58	0.34	0.34	0.59		0.32	-0.51	-0.13	0.56	0.01	-0.11	0.42	0.62	0.09	0.33	0.33	-0.13	0.19	-0.14
Cash And Short Term Investments	1.0	0.85	0.86	0.81	-0.92	0.73	0.84	-0.72	-0.59	0.08	0.72	0.32		0.26	-0.04	0.73	0.85	0.0	0.81	-0.36	0.77	1.0	1.0	-0.18	0.86	0.64
Common Stock Shares Outstanding	0.25	0.46	0.48	0.38	-0.59	0.71	0.25	0.22	-0.9	-0.56	-0.22	-0.51	0.26		-0.39	-0.06	0.7	-0.37	0.38	-0.68	0.63	0.25	0.24	-0.47	0.59	0.81
Non Current Liabilities Total	-0.06	-0.38	-0.31	-0.6	0.08	-0.62	-0.37	-0.36	0.46	0.74	0.36	-0.13	-0.04	-0.39		-0.33	-0.3	1.0	-0.6	0.15	-0.49	-0.06	-0.05	0.99	-0.37	-0.54
Other Current Assets	0.75	0.79	0.77	0.82	-0.55	0.57	0.89	-0.44	-0.32	0.13	0.44	0.56	0.73	-0.06	-0.33		0.6	-0.29	0.82	-0.25	0.72	0.75	0.74	-0.41	0.6	0.53
Other Stockholder Equity	0.85	0.9	0.91	0.84	-0.96	0.92	0.8	-0.36	-0.9	-0.22	0.36	0.01	0.85	0.7	-0.3	0.6		-0.26	0.84	-0.65	0.95	0.85	0.84	-0.45	0.94	0.94
Total Liab	-0.01	-0.33	-0.27	-0.56	0.04	-0.59	-0.33	-0.38	0.43	0.75	0.38	-0.11	0.0	-0.37	1.0	-0.29	-0.26		-0.56	0.12	-0.45	-0.01	0.0	0.98	-0.34	-0.5
Net Invested Capital	0.82	0.89	0.85	1.0	-0.76	0.91	0.89	-0.4	-0.68	-0.3	0.4	0.42	0.81	0.38	-0.6	0.82	0.84	-0.56		-0.32	0.9	0.82	0.82	-0.7	0.89	0.8
Long Term Investments	-0.37	-0.6	-0.65	-0.32	0.58	-0.57	-0.5	-0.28	0.79	0.19	0.28	0.62	-0.36	-0.68	0.15	-0.25	-0.65	0.12	-0.32		-0.67	-0.37	-0.36	0.24	-0.39	-0.74
Property Plant And Equipment Gross	0.78	0.96	0.96	0.9	-0.85	0.93	0.9	-0.19	-0.87	-0.23	0.19	0.09	0.77	0.63	-0.49	0.72	0.95	-0.45	0.9	-0.67		0.79	0.77	-0.62	0.85	0.95
Total Current Assets	1.0	0.86	0.86	0.82	-0.92	0.74	0.86	-0.71	-0.59	0.07	0.71	0.33	1.0	0.25	-0.06	0.75	0.85	-0.01	0.82	-0.37	0.79		1.0	-0.2	0.86	0.65
Net Working Capital	1.0	0.85	0.85	0.82	-0.92	0.73	0.85	-0.72	-0.58	0.08	0.72	0.33	1.0	0.24	-0.05	0.74	0.84	0.0	0.82	-0.36	0.77	1.0		-0.19	0.85	0.64
Common Stock	-0.2	-0.5	-0.44	-0.71	0.24	-0.73	-0.48	-0.27	0.58	0.73	0.27	-0.13	-0.18	-0.47	0.99	-0.41	-0.45	0.98	-0.7	0.24	-0.62	-0.2	-0.19		-0.51	-0.66
Property Plant Equipment	0.86	0.8	0.79	0.89	-0.92	0.92	0.72	-0.53	-0.8	-0.35	0.53	0.19	0.86	0.59	-0.37	0.6	0.94	-0.34	0.89	-0.39	0.85	0.86	0.85	-0.51		0.85
Capital Stock	0.65	0.84	0.85	0.8	-0.82	0.95	0.73	-0.05	-0.96	-0.44	0.05	-0.14	0.64	0.81	-0.54	0.53	0.94	-0.5	0.8	-0.74	0.95	0.65	0.64	-0.66	0.85

Click cells to compare fundamentals

Rallybio Corp Account Relationship Matchups

Rallybio Corp balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	141.9M	182.2M	180.4M	115.6M	68.1M	130.1M
Other Current Liab	4.3M	5.9M	9.3M	8.1M	5.0M	6.5M
Total Current Liabilities	5.8M	6.6M	10.7M	9.3M	6.2M	7.8M
Total Stockholder Equity	(47.0M)	175.6M	169.3M	106.2M	61.7M	81.6M
Property Plant And Equipment Net	287K	511K	909K	592K	267K	506.9K
Net Debt	(140.2M)	(175.3M)	(56.4M)	(24.1M)	(13.7M)	(14.4M)
Retained Earnings	(47.0M)	(94.0M)	(160.7M)	(235.2M)	(293.0M)	(278.4M)
Accounts Payable	1.6M	603K	1.1M	976K	278K	264.1K
Cash	140.2M	175.3M	57.0M	24.5M	13.9M	13.2M
Non Current Assets Total	597K	1.3M	939K	831K	267K	253.7K
Cash And Short Term Investments	140.2M	175.3M	169.0M	109.9M	65.5M	124.6M
Liabilities And Stockholders Equity	187.9M	182.2M	180.4M	115.6M	68.1M	103.5M
Non Current Liabilities Total	182.0M	32K	374K	173K	212K	201.4K
Other Current Assets	2.1M	10.7M	20.0M	4.9M	2.3M	2.2M
Other Stockholder Equity	183.0M	269.6M	330.2M	341.4M	354.7M	274.9M
Total Liab	187.9M	6.6M	11.1M	9.4M	6.5M	6.1M
Net Invested Capital	(46.0M)	175.6M	169.3M	106.2M	61.7M	81.8M
Property Plant And Equipment Gross	287K	717K	1.3M	1.1M	921K	828.9K
Total Current Assets	141.3M	180.9M	179.5M	114.8M	67.8M	129.3M
Accumulated Other Comprehensive Income	(230.0M)	0.0	(214K)	15K	17.3K	18.1K
Net Working Capital	135.4M	174.3M	168.8M	105.5M	61.6M	121.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Rallybio Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rallybio Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rallybio Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rallybio Corp Stock:

How To Invest In Rallybio

Details

Is Rallybio Stock a good investment?

Details

What is Rallybio Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rallybio Corp. If investors know Rallybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rallybio Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.33)

Revenue Per Share

0.015

Return On Assets

(0.39)

Return On Equity

(0.69)

The market value of Rallybio Corp is measured differently than its book value, which is the value of Rallybio that is recorded on the company's balance sheet. Investors also form their own opinion of Rallybio Corp's value that differs from its market value or its book value, called intrinsic value, which is Rallybio Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rallybio Corp's market value can be influenced by many factors that don't directly affect Rallybio Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Rallybio Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rallybio Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rallybio Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rallybio Historical Balance Sheet

About Rallybio Balance Sheet Analysis

Rallybio Corp Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Rallybio Corp balance sheet Correlations

Rallybio Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rallybio Corp balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Cash	- 1.0	Net Debt
Capital Stock	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.96	Other Liab
Retained Earnings	- 0.92	Net Tangible Assets
Property Plant Equipment	- 0.92	Other Liab
Net Working Capital	- 0.92	Other Liab